Cheryl Blanchard

Track

Insider profile

Currently holds positions in Neuronetics Inc and Anika Therapeutics Inc

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Neuronetics Inc Feb. 13, 2019 -
President, Chief Executive Officer, Director Anika Therapeutics Inc April 26, 2020 -
Interim Chief Executive Officer, Director Anika Therapeutics Inc Feb. 12, 2020 - April 26, 2020
Independent Director Anika Therapeutics Inc Aug. 31, 2018 - Feb. 12, 2020
Senior Vice President, Chief Scientific Officer Zimmer Biomet Holdings Inc Dec. 13, 2005 - Jan. 1, 2012
Cheryl Blanchard's trades of Anika Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-14 2022-03-11
B Purchase
62,588 -32.5%
408.45
US$2,505,124 		62,588 -32.5% 408.45 US$2,505,124
2022-03-14 2022-03-11
B Purchase
47,116 +0.8%
363.94
US$2,910,192 		47,116 +0.8% 363.94 US$2,910,192